Rethinking Pharma Funding
The pharmaceutical industry allocates more funds to marketing existing drugs than to researching new ones, raising concerns about priorities in healthcare. An economist proposes a radical shift: offering substantial cash prizes for breakthrough discoveries, like cures for cancer or malaria, instead of relying solely on patents. This approach could incentivize innovation while addressing neglected diseases, but it would require global cooperation to prevent free-riding by other countries.In this clip
From this podcast
Stuff You Should Know
How Intellectual Property Works
Related Questions